Anti-Citrullinated Protein Antibodies
"Anti-Citrullinated Protein Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies to citrullinated-peptides and proteins.
| Descriptor ID |
D000075422
|
| MeSH Number(s) |
D12.776.124.486.485.114.323.095 D12.776.124.790.651.114.323.095 D12.776.377.715.548.114.323.095
|
| Concept/Terms |
Anti-Citrullinated Protein Antibodies- Anti-Citrullinated Protein Antibodies
- Anti Citrullinated Protein Antibodies
- Antibodies, Anti-Citrullinated Protein
- Protein Antibodies, Anti-Citrullinated
- Citrullinated Protein Antibodies
- Antibodies, Citrullinated Protein
- Protein Antibodies, Citrullinated
- Anti-Citrullinated Peptide Antibodies
- Anti Citrullinated Peptide Antibodies
- Antibodies, Anti-Citrullinated Peptide
- Peptide Antibodies, Anti-Citrullinated
|
Below are MeSH descriptors whose meaning is more general than "Anti-Citrullinated Protein Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Anti-Citrullinated Protein Antibodies".
This graph shows the total number of publications written about "Anti-Citrullinated Protein Antibodies" by people in this website by year, and whether "Anti-Citrullinated Protein Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Citrullinated Protein Antibodies" by people in Profiles.
-
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 07 01; 59(7):1505-1513.
-
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol Immunol. 2021 06; 18(6):1528-1544.